Register Cart 0

Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe

Biography

Meet Our Editorial Board Member

Author(s): Andrey A. Zamyatnin Jr.

Volume 16, Issue 3, 2018

Page: [165 - 166] Pages: 2

DOI: 10.2174/187569211603190124125820

Next »

Rights & Permissions Print Cite

Article Metrics

38

2

1

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Dendrimers in Cancer Therapeutics and Diagnosis
Current Drug Metabolism

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Mini-Reviews in Medicinal Chemistry

Down with the Erythropoietin. Long Live the Erythropoietin !
Current Drug Targets

Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Current Medicinal Chemistry - Anti-Cancer Agents

Effect of Prostaglandins on the Regulation of Tumor Growth
Current Medicinal Chemistry - Anti-Cancer Agents

From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry

Vascular Adenosine Receptors; Potential Clinical Applications
Current Vascular Pharmacology

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C
Anti-Infective Agents in Medicinal Chemistry

Synergistic Approaches to Clinical Oncology Biomarker Discovery
Current Topics in Medicinal Chemistry

Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Recent Patents on Biotechnology

Imaging Agents in Targeting Tumor Hypoxia
Current Medicinal Chemistry

Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy
Mini-Reviews in Medicinal Chemistry

Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals

Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics

CRIM1, the Antagonist of BMPs, is a Potential Risk Factor of Cancer
Current Cancer Drug Targets

Annona sp: Plants with Multiple Applications as Alternative Medicine - A Review
Current Bioactive Compounds

New Strategies and Patent Therapeutics in EBV-Associated Diseases
Mini-Reviews in Medicinal Chemistry

Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Current Pharmaceutical Biotechnology

The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology

An Overview on 2-arylquinolin-4(1H)-ones and Related Structures as Tubulin Polymerisation Inhibitors
Current Topics in Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy